Work

Adverse event of ruxolitinib cream: a real-world analysis based on FDA Adverse Event Reporting System from 2021 to 2024

Year: 2024

Type: article

Study design: Observational Study

Source: Expert Opinion on Drug Safety

DOI: 10.1080/14740338.2024.2446432

Authors: Shu Zhou, Li Lei, Ling Jiang, Chuhan Fu, Jiangfeng Huang, Keyi Zhang, Yaqing Wen, Jing Chen, Qinghai Zeng

Institutions: Central South University, Third Xiangya Hospital, Xiangya Hospital Central South University

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Natural Science Foundation of Hunan Province

Award: G1359463739

OpenAlex ID: W4405659934

FWCI: 6.129

Cites: 29

Cited by: 8

Related to: 10